Skip to content

APOTHEEK SINT-MAARTEN: what changed

BE 0449.446.332NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€44,222
2024 · €46,338-€2,116
Equity
€434,858
2024 · €410,636+€24,222
Cash
€139,798
2024 · €117,254+€22,544
Balance sheet total
€550,816
2024 · €540,422+€10,394

Largest movements

2024 to 2025
Assets
  • Current investments -€49,725

    down €49,725 (-66.5%), from €74,725 to €25,000

  • Cash +€22,544

    up €22,544 (+19.2%), from €117,254 to €139,798

    mainly Current investments (+€49,725) and Net result for the year (+€44,222)

  • Receivables within one year +€20,469

    up €20,469 (+17.5%), from €116,677 to €137,146

    of which Trade receivables: +€12,912

  • Stocks and contracts +€19,216

    up €19,216 (+9.6%), from €201,072 to €220,289

Equity and liabilities
  • Reserves +€24,222

    up €24,222 (+6.9%), from €348,636 to €372,858

    of which Distributable reserves: +€24,222

  • Trade debts -€13,785

    down €13,785 (-22.6%), from €60,958 to €47,173

Income statement
  • Staff costs +€5,081

    up €5,081 (+6.6%), from €76,836 to €81,917

  • Depreciation -€1,983

    down €1,983 (-24.7%), from €8,021 to €6,037

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €46,338
Gross operating margin -€996
Staff costs -€5,081
Depreciation +€1,983
Other operating charges -€72
Financial income +€261
Financial charges +€949
Taxes +€839
Result 2025 €44,222
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€2,715
Investment +€45,259
Financing -€20,000
Cash 2024 €117,254
Net result for the year +€44,222
Depreciation +€6,037
Stocks and contracts -€19,216
Receivables within one year -€20,469
Deferred charges and accrued income +€539
Trade debts -€13,785
Tax, wage and social debts -€159
Smaller working-capital items +€116
Investment in fixed assets (net) -€4,466
Current investments +€49,725
Contributions, distributions and other -€20,000
Cash 2025 €139,798
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €540,422 €550,816 +€10,394 +1.9%
Fixed assets 21/28 €27,329 €25,758 -€1,571 -5.7%
Tangible fixed assets 22/27 €27,329 €25,758 -€1,571 -5.7%
Land and buildings 22 €17,250 €13,103 -€4,148 -24.0%
Plant, machinery and equipment 23 €9,564 €12,254 +€2,690 +28.1%
Furniture and vehicles 24 €514 €401 -€114 -22.1%
Current assets 29/58 €513,093 €525,058 +€11,965 +2.3%
Stocks and contracts in progress 3 €201,072 €220,289 +€19,216 +9.6%
Stocks 30/36 €201,072 €220,289 +€19,216 +9.6%
Amounts receivable within one year 40/41 €116,677 €137,146 +€20,469 +17.5%
Trade receivables 40 €97,291 €110,203 +€12,912 +13.3%
Other amounts receivable 41 €19,386 €26,943 +€7,557 +39.0%
Current investments 50/53 €74,725 €25,000 -€49,725 -66.5%
Cash at bank and in hand 54/58 €117,254 €139,798 +€22,544 +19.2%
Deferred charges and accrued income 490/1 €3,364 €2,825 -€539 -16.0%
Total equity and liabilities 10/49 €540,422 €550,816 +€10,394 +1.9%
Equity 10/15 €410,636 €434,858 +€24,222 +5.9%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €348,636 €372,858 +€24,222 +6.9%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €342,436 €366,658 +€24,222 +7.1%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €129,786 €115,958 -€13,828 -10.7%
Amounts payable within one year 42/48 €129,574 €115,667 -€13,907 -10.7%
Trade debts 44 €60,958 €47,173 -€13,785 -22.6%
Suppliers 440/4 €60,958 €47,173 -€13,785 -22.6%
Taxes, remuneration and social security 45 €20,307 €20,148 -€159 -0.8%
Taxes 450/3 €7,623 €9,009 +€1,386 +18.2%
Remuneration and social security 454/9 €12,684 €11,140 -€1,545 -12.2%
Other amounts payable 47/48 €48,309 €48,346 +€37 +0.1%
Accrued charges and deferred income 492/3 €212 €290 +€79 +37.3%
Remuneration, social security and pensions 62 €76,836 €81,917 +€5,081 +6.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,021 €6,037 -€1,983 -24.7%
Other operating charges 640/8 €2,359 €2,431 +€72 +3.0%
Gross operating margin 9900 €144,833 €143,837 -€996 -0.7%
Operating profit (loss) 9901 €57,617 €53,452 -€4,166 -7.2%
Financial income 75/76B €2,540 €2,801 +€261 +10.3%
Recurring financial income 75 €2,540 €2,801 +€261 +10.3%
Financial charges 65/66B €4,236 €3,287 -€949 -22.4%
Recurring financial charges 65 €4,236 €3,287 -€949 -22.4%
Profit (loss) for the period before taxes 9903 €55,921 €52,966 -€2,955 -5.3%
Income taxes 67/77 €9,583 €8,744 -€839 -8.8%
Profit (loss) for the period 9904 €46,338 €44,222 -€2,116 -4.6%
Profit (loss) for the period to be appropriated 9905 €46,338 €44,222 -€2,116 -4.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€329,664 to €374,559

Midpoint €348,370 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €434,858
Capitalised earnings €224,471 to €314,260
Indication €329,664 to €374,559

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€434,858
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€434,858

Capitalised earnings

net result for the year (9904)
2025
€44,222
2024
€46,338
2023
€3,719
2022
€7,527
2021
-€5,558
Average result
€31,426
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€224,471 / €261,883 / €314,260

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 8 November 2026 via checked.be.